All
Update on hepatoprotective therapies (Proceedings)
November 1st 2010Hepatoprotective agents are receiving attention for their role in the ancillary treatment of liver disease in dogs and cats. These products include both prescription drugs and dietary supplements (vitamins, minerals, herbs, nutraceuticals). A drug is defined as "any substance, food, or nonfood that is used to treat, cure, mitigate, or prevent a disease and any nonfood substance that is intended to affect the structure or function of man or animals".
Care of the canine and feline neonate: part 1 (Proceedings)
November 1st 2010Puppies and kittens are generally considered to be neonates from birth to two weeks of age although some references consider the neonate period to extend to four weeks of age. Neonates pose special problems in husbandry and health care due to their small size and developing organ systems.
Management of hypokalemia and hyperkaemia (Proceedings)
November 1st 2010Over 90% of the potassium in the body is located within cells. External balance for potassium is maintained by matching output to input. Internal balance is maintained by translocation of potassium between intracellular and extracellular fluid. Any change in plasma potassium concentration must arise from a change in intake, distribution, or excretion.
Do's and don'ts of decontamination (Proceedings)
November 1st 2010A number of factors need to be considered in deciding the best approach to decontaminating a toxicant-exposed patient. In animals orally exposed to toxicants, these factors include consideration of the substance and amount ingested, whether multiple agents were ingested, the time since ingestion, whether attempts at decontamination have been undertaken prior to presentation, the species of animal involved, number of individuals exposed and whether there is any known underlying organ dysfunction, especially affecting the liver or kidneys.
AAHA severs ties with the National Commission on Veterinary Economic Issues
November 1st 2010National Report - Following 10 years of supporting the National Commission on Veterinary Economic Issues (NCVEI), the American Animal Hospital Association (AAHA) will withdraw its membership and financial support at the end of the year.
Practical transfusion therapy (Proceedings)
November 1st 2010The transfusion of blood products to treat acute blood losses, coagulopathies, and severe anemia has become indispensable in the care of critically ill veterinary patients. As with any therapy, the risks, cost and potential benefits associated with the use of blood products must be carefully considered and every effort should be made to minimize the occurrence of adverse effects.
Case study: monensin (Rumensin) toxicity in dairy replacement heifers (Proceedings)
November 1st 2010Many dairy producers use Rumensin? (Elanco Animal Health) in dairy heifers as an aid to controlling coccidiosis and for improved feed efficiency. Rumensin? also is approved for use in lactating cows as a tool for improving milk production efficiency. Monensin, the active compound in Rumensin?, has a very wide safety margin for humans and cattle. But, it can be toxic if not fed according to the FDA-approved label. In other species, such as horses, monensin can be extremely toxic.